Advantage Alpha Capital Partners LP Charles River Laboratories International, Inc. Transaction History

Advantage Alpha Capital Partners LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$351.38 - $448.68 $3.62 Million - $4.63 Million	-10,311 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$372.64 - $458.3 $1.76 Million - $2.16 Million	-4,710 Reduced 31.36%	10,311 $4.26 Million
Q2 2021 Aug 16, 2021	SELL	$294.17 - $371.65 $557,157 - $703,905	-1,894 Reduced 11.2%	15,021 $5.56 Million
Q1 2021 May 13, 2021	SELL	$249.67 - $299.48 $3.24 Million - $3.89 Million	-12,982 Reduced 43.42%	16,915 $4.9 Million
Q4 2020 Feb 16, 2021	SELL	$222.0 - $252.62 $1.04 Million - $1.19 Million	-4,692 Reduced 13.57%	29,897 $7.47 Million
Q3 2020 Nov 16, 2020	SELL	$175.56 - $226.45 $41,607 - $53,668	-237 Reduced 0.68%	34,589 $7.83 Million
Q2 2020 Aug 13, 2020	BUY	$118.84 - $189.72 $4.14 Million - $6.61 Million	34,826 New	34,826 $6.07 Million

695

52.2M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.45B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Advantage Alpha Capital Partners LP, based on Form 13F filings with the SEC.

Stay updated on Advantage Alpha Capital Partners LP with notifications on news.